Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Liabilities and Shareholders Equity (2016 - 2025)

Qiagen (QGEN) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $6.3 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 10.4% to $6.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.4 billion through Dec 2025, up 0.55% year-over-year, with the annual reading at $6.3 billion for FY2025, 10.4% up from the prior year.
  • Liabilities and Shareholders Equity hit $6.3 billion in Q4 2025 for Qiagen, up from $5.7 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $6.3 billion in Q4 2022 to a low of $5.7 billion in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $6.1 billion across 5 years, with a median of $6.1 billion in 2021.
  • Biggest five-year swings in Liabilities and Shareholders Equity: decreased 6.96% in 2024 and later increased 10.4% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $6.1 billion in 2021, then increased by 2.29% to $6.3 billion in 2022, then dropped by 2.74% to $6.1 billion in 2023, then fell by 6.96% to $5.7 billion in 2024, then rose by 10.4% to $6.3 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for QGEN at $6.3 billion in Q4 2025, $5.7 billion in Q4 2024, and $6.1 billion in Q4 2023.